Elissa Schwartz

Infectious Disease Dynamics.

1. HIV-1 Induces Loss of Contact Inhibition in Podocytes (with A. Cara, H. Snoeck, M.D. Ross, M. Sunamoto, J. Reiser, P. Mundel, and P.E. Klotman), J Am Soc Nephrol, 12(8) (2001), 1677-84.

2. Effect of Target Cell Availability on HIV-1 Production in Vitro (with A.U. Neumann, A.V. Teixeira, L.A. Bruggeman, J. Rappaport, A.S.Perelson, and P.E. Klotman), AIDS, 16(3) (2002), 341- 345.

3. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes (with M. Husain, G.L. Gusella, M.E. Klotman, I.H. Gelman, M.D. Ross, A. Cara, and P.E. Klotman), J Am Soc Nephrol, 13(7) (2002), 1806-15.

4. HIV-1 Dynamics in Hemodialysis Patients (with. D.S. Fierer, A.U. Neumann, M.J. Keller, V. Parkas, M.E. Klotman, J.A. Winston, and P.E. Klotman), AIDS, 16(9) (2002), 1301-1303.

5. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines (with S.M. Blower and J. Mills), AIDS Reviews, 5(2) (2003), 113-125.

6. Critical Role for Nef in HIV-1-induced podocyte dedifferentiation (with M. Sunamoto, M. Husain, J.C. He, and P.E. Klotman), Kidney Int, 64(5) (2003), 1695-1701.

7. Highly Active Antiretroviral Therapy and the Epidemic of HIV+ End-Stage Renal Disease (with L.A. Szczech, M.J. Ross, M.E. Klotman, J.A, Winston and P.E. Klotman), J Am Soc Nephrol, 16(8) (2005), 2412-20.

8. Predicting the Potential Individual- and Population-Level Effects of Imperfect Herpes Simplex Virus Type 2 Vaccines, (with S.Blower), J Infect Dis, 191(10) (2005), 1734-46.

9. Modeling the Potential Impact of Rectal Microbicides to Reduce HIV Transmission in Bathhouses (with R. Breban, I. McGowan I, C. Topaz, P. Anton, and S.Blower), Mathematical Biosciences and Engineering, 3(3):4 (2006), 59-66.